GUANGZHOU, Chine, 22 mai 2023 /PRNewswire/ — Les questions de santé mondiale occupent le devant de la scène tandis que tous les pays se remettent de la pandémie de COVID-19. À mesure que le public devient plus vigilant au sujet de sa santé, les établissements médicaux intensifient également leurs efforts en fournissant des services et … Read more
The company reported 171 million for the last twelve months, with a 60% growth in net revenue and its best EBITDA ever SÃO PAULO, May 21, 2023 /PRNewswire/ – Oncoclínicas Group (ONCO3) – the largest group dedicated to cancer treatment in Latin America – announced its results for the first quarter of 2023, marking its … Read more
The company reported 171 million for the last twelve months, with a 60% growth in net revenue and its best EBITDA ever SÃO PAULO, May 21, 2023 /PRNewswire/ – Oncoclínicas Group (ONCO3) – the largest group dedicated to cancer treatment in Latin America – announced its results for the first quarter of 2023, marking its … Read more
SHANGHAI and WARREN, N.J. , May 21, 2023 /PRNewswire/ — Laekna, a clinical-stage biotechnology company dedicated to bringing novel therapies to cancer and liver fibrosis patients worldwide, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of LAE102 antibody to initiate clinical development. This is Laekna’s first … Read more
VERO BEACH, Fla., May 20, 2023 /PRNewswire/ — During the second week of May, the residents and staff of Watercrest St. Lucie West Assisted Living and Memory Care designated a special time each day to recognize their nurses who are critically important in ensuring the safety, health and happiness of their Watercrest senior living residents. … Read more
Additional real-world outcomes further demonstrate safety, efficacy and procedural reproducibility of the FARAPULSE™ Pulsed Field Ablation System* Results from global trial of the POLARx™ Cryoablation System* meet safety and effectiveness endpoints MARLBOROUGH, Mass., May 20, 2023 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced data supporting use of the company’s key electrophysiology and cardiac … Read more
SAN DIEGO, May 20, 2023 /PRNewswire/ — CureScience™ Institute, a San Diego, California based non-profit 501(c)(3) dedicated to accelerating cures based on a combination of diagnostic, immunological, and regenerative approaches, proudly announce that Professor Igor Tsigelny and Professor Valentina Kouznetsova, both of UC San Diego, will again offer an educational program in bioinformatics for undergraduate and high-school … Read more
– La primera de su clase en el mundo: La Administración Nacional de Productos Médicos de China ha aprobado para ensayos clínicos la vacuna recombinante multivalente de proteína de la COVID-19 contra las variantes XBB de WestVac Biopharma/West China Medical Center, Sichuan University CHENGDU, China, 20 de mayo de 2023 /PRNewswire/ — El 17 de mayo … Read more
ČCHENG-TU, Čína, 20. května 2023 /PRNewswire/ — Dne 17. května 2023 získala rekombinantní bivalentní proteinová vakcína COVID-19 (buňky Sf9) a rekombinantní trivalentní proteinová vakcína COVID-19 (buňky Sf9) proti nejnovějším cirkulujícím variantám XBB vyvinutá společností WestVac Biopharma/ West China Medical Center (Sečuánská univerzita) „Schválení pro klinické zkoušky léčiv” od čínské Národní správy léčivých přípravků. Po dokončení … Read more
CHENGDU, Chin, 20 maja 2023 r. /PRNewswire/ — 17 maja 2023 r. rekombinowana dwuskładnikowa szczepionka białkowa na COVID-19 (komórki Sf9) oraz rekombinowana trójskładnikowa szczepionka na COVID-19 oparta o białko trimerowe (komórki Sf9) opracowana przez WestVac Biopharma/ Centrum Medyczne Zachodnich Chin, Uniwersytet Syczuański przeciwko najnowszym krążącym wariantom XBB, uzyskała „Dopuszczenie leku do badań klinicznych” wystawione przez … Read more